PF-08653945 + PF-08653944 for Obesity
(SOLIS-1 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Who Is on the Research Team?
Pfizer CT.gov Call Center
Principal Investigator
Pfizer
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive subcutaneous injections of PF-08653945, PF-08653944, or placebo for weight loss
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PF-08653944
- PF-08653945
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants receive subcutaneous injections of PF-08653945 + PF-08653944 , PF-08653944 , or placebo.
Participants receive subcutaneous injections of PF-08653945 + PF-08653944 or placebo.
Participants receive subcutaneous injections of PF-08653945 or placebo.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pfizer
Lead Sponsor
Albert Bourla
Pfizer
Chief Executive Officer since 2019
PhD in Biotechnology of Reproduction, Aristotle University of Thessaloniki
Patrizia Cavazzoni
Pfizer
Chief Medical Officer
MD from McGill University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.